Carson Wealth (CWM LLC)
TELO icon

Carson Wealth (CWM LLC)’s Telomir Pharmaceuticals TELO Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2
Closed – – 5693
2025
Q3 		$0 Sell
2
-2,705
-100% -$4.08K ﹤0.01% 5596
2025
Q2 		$3K Buy
2,707
+2,038
+305% +$4.71K ﹤0.01% 4828
2025
Q1 		$2K Buy
669
+569
+569% +$2.49K ﹤0.01% 4837
2024
Q4 		$0 Buy
100
+28
+39% +$132 ﹤0.01% 5208
2024
Q3 		$0 Buy
+72
New +$351 ﹤0.01% 5208

Other funds holding TELO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $798M AUM 14.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return

Carson Wealth (CWM LLC)'s TELO Position: Q4 2025 in Review

Carson Wealth (CWM LLC) sold out of Telomir Pharmaceuticals (TELO) in Q4 2025, closing a stake of 2 shares.

Carson Wealth (CWM LLC) first reported a position in TELO in Q3 2024 and held it in 5 quarters. The position peaked at $3K in Q2 2025. 33 funds tracked by Wall St. Rank hold TELO as of Q4 2025.

  • Carson Wealth (CWM LLC) reported no remaining Telomir Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 2 Telomir Pharmaceuticals shares in Q4 2025.
  • Carson Wealth (CWM LLC) first reported a position in Telomir Pharmaceuticals in Q3 2024 and held it in 5 quarters.
  • Carson Wealth (CWM LLC)'s Telomir Pharmaceuticals position peaked at $3K in Q2 2025.
  • 33 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q4 2025.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2025, filed 26 Jan 2026.